At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 185 enrolled
Drug / intervention
Norco +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Quantifying Narcotic Use in Outpatient Otolaryngology Procedures
In Brief
A Phase 3 clinical trial evaluating Norco and Ibuprofen for Outpatient Surgery and Pain, Postoperative. Completed, enrolled 185 participants across 2 sites.
Detailed Summary
Patient's pain level and narcotic requirements will be evaluated after routine outpatient Otolaryngology procedures. This will be done by having study participants record their pain level and medication usage from home.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOutpatient Surgery, Pain, Postoperative
CountriesUnited States
Collaborators--
Timeline
Phase 3CompletedFinished
201820192020202120222023202420252026
First PostedJan 2018
Enrollment StartFeb 2018
Primary CompletionOct 2018
TodayJul 2026
First PostedJan 19, 2018
Enrollment StartFeb 21, 2018
Primary CompletionOct 1, 2018
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 8.5 years ago
Interventions
Norcodrug
Hydrocodone/Acetaminophen as first line therapy every 6 hours as needed for pain control
Ibuprofendrug
Ibuprofen as first line therapy every 6 hours as needed for pain control